My Account Log in

1 option

CADTH Canadian Drug Expert Committee recommendation : indication : for the treatment of adults with acquired thrombotic thrombocytopenic purpura. Caplacizumab (Cablivi-Sanofi-Aventis Canada Inc.) / Canadian Agency for Drugs and Technologies in Health.

NCBI Bookshelf Available online

View online
Format:
Book
Author/Creator:
Canadian Agency for Drugs and Technologies in Health, author, issuing body.
Language:
English
Subjects (All):
Drugs--History.
Drugs.
Physical Description:
1 online resource
Edition:
Version: Final.
Place of Publication:
Ottawa, ON : Canadian Agency for Drugs and Technologies in Health, 2020.
Notes:
Description based on publisher supplied metadata and other sources.

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account